Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Otsuka
Otsuka
Otsuka Can Block Generic Abilify as Court Rejects Appeal
Bloomberg
Mon, 01/14/13 - 12:27 pm
generics
Abilify
Otsuka
schizophrenia
It's Hard to Make Money When FDA Approvals Are Priced In
Motley Fool
Mon, 12/17/12 - 09:31 am
FDA
drug approvals
Ariad Pharmaceuticals
Novartis
Dendreon
Medivation
Bayer
ONYX Pharmaceuticals
Otsuka
Bristol-Myers Squibb
Claris Lifesciences to form JV with Otsuka and Mitsui
Equity Bulls
Sun, 12/9/12 - 01:22 pm
Claris Lifesciences
Otsuka
Mitsui
Otsuka's Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Tolvaptan, Meets Primary Endpoint in a Phase III Clinical Trial
Business Wire
Sun, 11/4/12 - 10:54 am
Otsuka
Tolvaptan
autosomal dominant polycystic kidney disease
kidney disease
Sanofi, Otsuka amp up their Turkish ambitions
Fierce Pharma
Fri, 08/3/12 - 11:29 am
Otsuka
Sanofi
Turkey
Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML
news-medical.net
Sat, 06/16/12 - 02:12 pm
Otsuka
Bristol-Myers Squibb
Sprycel
leukemia
chronic myeloid leukemia
First Tuberculosis Drug In 40 Years Has Otsuka Cautious
Bloomberg
Thu, 06/7/12 - 11:03 am
tuberculosis
Otsuka
delamanid
JacksonWhite Files Overtime Lawsuit Against Otsuka America Pharmaceuticals
Manufacturing Digital
Sat, 05/12/12 - 12:42 pm
overtime lawsuits
lawsuits
Otsuka
Some antipsychotics raise risks of death in dementia patients - study
Pharma Times, UK
Fri, 02/24/12 - 11:30 am
dementia
antipsychotics
Otsuka
Abilify
Bristol-Myers Squibb
AstraZeneca
Seroquel
Haldol
JNJ
Eli Lilly
Zyprexa
Geodon
Pfizer
Risperdal
Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders
Pipeline Review
Sat, 01/14/12 - 12:21 pm
Cimzia
Otsuka
UCB Pharmaceuticals
JV could solve Otsuka's patent problem
The Deal
Tue, 11/15/11 - 01:46 pm
Otsuka
Lundbeck
Abilify
Drugmakers Lundbeck, Otsuka form global alliance
Reuters
Fri, 11/11/11 - 09:46 am
Otsuka
Lundbeck
aripiprazole depot
OPC-34712
Otsuka Sets Price for $2.4 Billion Tokyo IPO at the Lower End of Its Range
Bloomberg
Mon, 12/6/10 - 11:30 am
Otsuka
Japan
IPOs
Bristol-Myers, Otsuka's Schizophrenia Drug Backed for Teens by U.K. Agency
Bloomberg
Wed, 12/1/10 - 08:08 am
Bristol-Myers Squibb
Otsuka
schizophrenia
aripiprazole
UK
Abilify
Bristol-Myers Partner Otsuka Wins Abilify Ruling
Bloomberg
Tue, 11/16/10 - 09:36 am
Otsuka
Bristol-Myers Squibb
Abilify
patents
Teva Pharmaceuticals
Sun Pharma
Sandoz
Apotex
MethylGene Reports Third Quarter 2010 Financial Results and Provides Clinical Update for MGCD265
PR-USA.net
Sun, 11/14/10 - 01:09 pm
MethylGene
earnings
Otsuka
MGCD265
cancer
Otsuka plots $2.8B IPO
Fierce Biotech
Fri, 11/12/10 - 09:51 am
IPOs
Otsuka
Otsuka Said to Hire Morgan Stanley, Nomura, UBS to Manage Drugmaker's IPO
Bloomberg
Thu, 09/2/10 - 04:21 pm
Japan
Otsuka
IPOs
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
Yahoo/BusinessWire
Sat, 07/10/10 - 11:39 am
Sprycel
chronic myeloid leukemia
BMS
Otsuka
Otsuka Pharma extends research collaboration with MethylGene
Pharmabiz
Sat, 07/3/10 - 10:50 am
Otsuka
MethylGene
eye disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »